Profile

Cover photo
The Cheap Investor
43 followers|13,033 views
AboutPostsPhotosVideos

Stream

The Cheap Investor

Shared publicly  - 
 
The Hidden Danger In Biotech Stocks - There’s a hidden danger in biotech stocks few investors can see right now. The danger is very real and will cause a lot investors to miss out on one of the best investment opportunities you can find the next few years. But if you identify this danger now and learn specifically how to protect yourself from it, the biotech bull market could provide you with serious gains in the next couple of years. Here’s what you need to know now and what to do about it...
There’s a hidden danger in biotech stocks few investors can see right now. The danger is very real and will cause a lot investors to miss out on one of the best investment opportunities you can find the next few years. But if you identify this danger now and learn specifically how to protect yourself from it, the biotech bull market could provide you with serious gains in the next couple of years.
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Why Now is the Best Time to Buy These High-Flying Biotech Stocks http://ow.ly/2Zkj8F
-*+Every year in late May 30,000 oncology professionals from around the world gather in one place - the world's largest oncology conference - to discuss the latest groundbreaking cancer research. You won’t ever see this much knowledge, experience and exposure of the most groundbreaking cancer research in the same place anywhere else in the world. Biotech companies pay thousands of dollars just to get a small 10 foot by 10 foot space on the...
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
The Last Time This Happened Stocks Dropped 20% - This has only happened twice the last six years. Each time was a disaster for most investors. Yet it created a wildly profitable for investors who saw it coming. Here’s what it is and how to make sure you’re one of the few who benefits from it. The Last Time This Happened Stocks Dropped 20% As I said, this has only occurred twice in the past six years and major corrections followed both times it happened. It’s not just on... http://ow.ly/2Z9TDH
-*+As I said, this has only occurred twice in the past six years and major corrections followed both times it happened. It’s not just one indicator though. It’s actually a combination of two factors which makes it much harder to see. The first factor is a low reading on the CBOE S&P 500 Volatility Index, a.k.a. the “VIX” or “Fear Index.” When this index is low it signals a high level of confidence and complacency among investors.
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Is the Biotech Bubble About to Burst? - [Biotech stocks] are beginning to dangerously resemble the dotcom mania of the 90s. That’s the warning from the Telegraph last week. The timing of the warning isn’t surprising. The Nasdaq Biotechnology Index fell 10% last week. It is only it’s fourth 10% or greater decline in the past five years. Naturally, with the stocks already down a bit, the expectation for the short-term trend to continue indefinitely into the future. And si... http://ow.ly/2WGY77
-*+[Biotech stocks] are beginning to dangerously resemble the dotcom mania of the 90s. That’s the warning from the Telegraph last week. The timing of the warning isn’t surprising. The Nasdaq Biotechnology Index fell 10% last week. It is only it’s fourth 10% or greater decline in the past five years.
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Investing 101: Twelve Tips for Investing Success - No one ever became a rocket scientist – or a stock-picking genius (like us) – overnight. We all had to start somewhere, reading, studying, noting what others are doing and have done. To succeed in today’s market, it’s all about education. Without it, you’re driving with blinders. You’re throwing money at stocks, thinking it's a slot machine with immediate certain pay out. But that's not how this works. That’s not how an... http://ow.ly/2VtyId
No one ever became a rocket scientist – or a stock-picking genius (like us) – overnight. We all had to start somewhere, reading, studying, noting what others are doing and have done. To succeed in today’s market, it’s all about education. Without it, you’re driving with blinders. You’re throwing money at stocks, thinking it's a…
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Biotech Boom: ACADIA Pharmaceuticals at New Highs - I’ve traded the markets for decades. And I have yet to see anything as impressive as this. After picking up beaten-down shares of ACADIA at just $1.05 and $1.24 in 2010, we just watched the stock hit a high of $35 a share. That’s a four-year gain of 3,233% and 2,723%. Every $5,000 invested is now worth well over $165,500 in four years. The bread and butter of The Cheap Investor is to buy stocks of the same caliber. Her... http://ow.ly/2UPSGU
I’ve traded the markets for decades. And I have yet to see anything as impressive as this. After picking up beaten-down shares of ACADIA at just $1.05 and $1.24 in 2010, we just watched the stock hit a high of $35 a share. That’s a four-year gain of 3,233% and 2,723%. Every $5,000 invested is…
1
Add a comment...
Have them in circles
43 people
Chuck Carnevale's profile photo
South East Property Depot's profile photo
JoanAnn Malarkey's profile photo
Alecia Hutton's profile photo
Billyzoel Batubara's profile photo
Perry Immerman's profile photo
Kurt Braun's profile photo
Cassidy Samantha's profile photo
K abdul's profile photo

The Cheap Investor

Shared publicly  - 
 
Biotech Stocks Are Soaring…These Stocks Are Better - “Valuation metrics in some sectors do appear substantially stretched—particularly those for smaller firms in the social media and biotechnology industries.” That’s what Janet Yellen, the head of the Federal Reserve, stated 11 months ago. The warning couldn’t have been more wrong. Since then the Nasdaq Biotechnology Index rose 54%. Now, that’s an extreme gain for any sector in just 11 months. Probably too extreme. Almo... http://ow.ly/30udRG
“Valuation metrics in some sectors do appear substantially stretched—particularly those for smaller firms in the social media and biotechnology industries.” That’s what Janet Yellen, the head of the Federal Reserve, stated 11 months ago.
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Is the Biotech Sector About to Get a Big Boost? - Now is the time to create or add to your positions in the biotech sector? But you have to be strategic about it. And why now? Every year in late May 30,000 oncology professionals gather in one place – the world’s largest oncology conference –  to discuss groundbreaking cancer research and which companies in the sector are best positioned to take advantage of these revelations. Once that information is released to the pub... http://ow.ly/2ZgkMG
-*+Now is the time to create or add to your positions in the biotech sector? But you have to be strategic about it. And why now? Every year in late May 30,000 oncology professionals gather in one place - the world's largest oncology conference - to discuss groundbreaking cancer research and which companies in the sector are best positioned to take advantage of these revelations.
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Why Did This Billionaire Sell All His Stocks? - Mohamed El-Erian has never been just a “typical investor.” His grasp of the cross currents impacting the investment world is impeccable. Few have been as influential or accurate. In 1999, he dumped $2 billion of Argentine debt two years before the country defaulted. At the time, no one believed the country would stop paying its debts. In 2002, he took a bullish position on Brazilian bonds as rivals sold on concerns that ne... http://ow.ly/2Xw3Z1
-*+Mohamed El-Erian has never been just a “typical investor.” His grasp of the cross currents impacting the investment world is impeccable. Few have been as influential or accurate.
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Cheap Copper Stocks: Copper Rallies… But Can it last? - Copper has taken it on the chin. But after a 48% fall from 2011 highs, we are seeing small pockets of strength. In fact, some analysts are pointing to seasonality in copper inventory, noting that numbers rise until April before tumbling for the remainder of the year. Others are bullish as China – the largest buyer of copper -- cut interest rates for the second time in three months to spur economic growth. Lundin Mi... http://ow.ly/2Vue2G
Copper has taken it on the chin. But after a 48% fall from 2011 highs, we are seeing small pockets of strength. In fact, some analysts are pointing to seasonality in copper inventory, noting that numbers rise until April before tumbling for the remainder of the year. Others are bullish as China – the largest…
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Investing 101: Fundamental v. Technical Analysis - Which school of thought do you fall under? Fundamental analysis helps us value a stock to determine an overvalued or undervalued opportunity. It dives into the economics of the company itself, such as sales and profits as well as external factors like politics. With fundamental analysis, we’re examining a company’s financial statement to discover if it’s selling below fair value. If we bought a company and wait for ever... http://ow.ly/2V2LOv
Which school of thought do you fall under? Fundamental analysis helps us value a stock to determine an overvalued or undervalued opportunity. It dives into the economics of the company itself, such as sales and profits as well as external factors like politics. With fundamental analysis, we’re examining a company’s financial statement to discover if…
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Office Retailer Merger: Staples to Buy Office Depot - Staples agreed to buy Office Depot for $6.3 billion. And it could force greater scrutiny.  But as we mentioned February 3, the competitive landscape has changed significantly. In fact, here’s what we noted. Office Depot (ODP) is rocketing to highs not seen since 2010. Staples (SPLS) just popped to highs not seen since 2011. And it’s all thanks to a Wall S3, 2015, eet Journal’s report that Staples is in advanced talks... http://ow.ly/2Ug4sQ
Staples agreed to buy Office Depot for $6.3 billion. And it could force greater scrutiny.  But as we mentioned February 3, the competitive landscape has changed significantly. In fact, here’s what we noted. Office Depot (ODP) is rocketing to highs not seen since 2010. Staples (SPLS) just popped to highs not seen since 2011. And…
1
Add a comment...
People
Have them in circles
43 people
Chuck Carnevale's profile photo
South East Property Depot's profile photo
JoanAnn Malarkey's profile photo
Alecia Hutton's profile photo
Billyzoel Batubara's profile photo
Perry Immerman's profile photo
Kurt Braun's profile photo
Cassidy Samantha's profile photo
K abdul's profile photo
Contact Information
Contact info
Phone
(877) 306-4256
Email
Story
Tagline
Founded in 1981 by Bill Mathews, The Cheap Investor newsletter is all about discovering quality stocks trading for less than $5 per share.
Introduction
Since 1981, The CHEAP Investor newsletter has been an intelligent and straightforward guide to choosing low-price quality stocks and has helped thousands of investors make profitable investment decisions. Subscribers get the information that they need to purchase stocks with great profit potential at the lowest price. The CHEAP Investor was rated the #1 Best Performing Market Letter for the five-year period ending November 2006, by Select Information Exchange and one of the four best small stock advisories in America by the League of American Investors.


Bill Mathews
Recognized as one of the foremost authorities on investing in small-cap stocks, Bill Mathews has been a frequent guest on radio and television shows nationwide such as CNBC. He has been interviewed by major newspapers and magazines including the Wall Street Journal, Business Week, Barrons and the Chicago Tribune. Bill Mathews is the author of the book "Making Big Money in Small Stocks" which describes specific techniques for analyzing stocks easily and profitably as well as determining what might affect a stock's profit potential. Mr. Mathews also taught securities analysis for the MBA program at the Keller Graduate School of Management, and spent 15 years teaching business and investment courses at Triton College.